72F fusion protein vaccine
Topic: Medicine
From HandWiki - Reading time: 3 min
72F fusion protein vaccine is a candidate tuberculosis vaccine created by Statens Serum Institut (SSI). The 72F fusion protein is composed of the Rv0125 and Rv1196 proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.
See also
- Fusion protein
References
- Kaufmann SHE, McMichael AJ (2005). "Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis". Nature Medicine 11 (4 suppl): S33–S44. doi:10.1038/nm1221. PMID 15812488.
 |
Licensed under CC BY-SA 3.0 | Source: https://handwiki.org/wiki/Medicine:72F_fusion_protein_vaccine3 views | Status: cached on February 04 2026 18:32:01↧ Download this article as ZWI file
EncycloReader
is supported by the 
KSF